Commentary

Cancer Immunology, Immunotherapy

, Volume 57, Issue 3, pp 285-288

Open Access This content is freely available online to anyone, anywhere at any time.

Toward the harmonization of immune monitoring in clinical trials: Quo vadis?

  • C. M. BrittenAffiliated withDepartment of Immunohaematology and Blood Transfusion, Leiden University Medical Center Email author 
  • , S. JanetzkiAffiliated withZellNet Consulting, Inc.
  • , S. H. van der  BurgAffiliated withDepartment of Clinical Oncology, Leiden University Medical Center
  • , C. GouttefangeasAffiliated withDepartment of Immunology, University of Tuebingen
  • , A. HoosAffiliated withBristol-Myers Squibb